• RaySearch management briefed investors on Q2 2026 results at an earnings presentation led by CEO Johan Löf, joined by CFO Nina Grönberg.
• Net sales fell 11% to SEK 272 million; EBIT was SEK 28 million, margin 10%, hit by postponed U.S. deals.
• Order intake rose 23% with a 1.1 book-to-bill; backlog reached SEK 1.69 billion, with SEK 670 million due within 12 months.
• Early Q3 brought nine U.S. RayStation orders worth about $5 million; management expects Q2-slipped orders to be recovered in Q3.
• Operating margin target of at least 25% for 2026 was reiterated; management expects a strong second half supported by U.S. momentum.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RaySearch Laboratories AB published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.